Overview

The Effect of Combination of Dapagliflozin and Sildenafil in Treatment of Heart Failure Patients With Secondary Pulmonary Hypertension

Status:
COMPLETED
Trial end date:
2025-08-01
Target enrollment:
Participant gender:
Summary
This study aims to determine the efficacy of sildenafil (improve PAH) as an add-on therapy to dapagliflozin in the treatment of heart failure patients with secondary pulmonary arterial hypertension and compare the result with monotherapy dapagliflozin
Phase:
NA
Details
Lead Sponsor:
Fayoum University
Treatments:
dapagliflozin
Sildenafil Citrate